Oxidants play an important role in the cell and are involved in many redox processes. Oxidant concentrations are maintained through coordinated production and removal systems. The dysregulation of oxidant homeostasis is a hallmark of many disease pathologies. The local oxidant microdomain is crucial for the initiation of many redox signaling events; however, methods to control oxidant product are limited. Some fluorescent proteins, including GFP, TagRFP, KillerRed, miniSOG, and their derivatives, generate oxidants in response to light. These genetically-encoded photosensitizers produce singlet oxygen and superoxide upon illumination and offer spatial and temporal control over oxidant production. In this review, we will examine the photosensitization properties of fluorescent proteins and their application to redox biology. Emerging concepts of selective oxidant species production via photosensitization and the impact of light on biological systems are discussed.
Introduction
Oxidants, such as superoxide (O 2
•-) and hydrogen peroxide (H 2 O 2 ) have a multifaceted role in cells. The endogenous production of oxidants contributes to both destructive pathways and cell signaling [1] . The controlled production of oxidants can activate redox signaling pathways and is important for maintaining homeostasis [1] . However, the overproduction of oxidants, such as during reperfusion injury, leads to toxicity and death of the cell [2] . Dysregulation of oxidant production is associated with numerous pathologies, however, attempts to treat disease with antioxidants such as vitamin E have been unsuccessful and suggest the role of oxidants in the cell is more complex than originally thought [3] . For example, the antioxidant may not selectivity target the oxidant and instead lead to global changes in redox homeostasis [4] . Moreover, antioxidants would have to achieve high concentrations to compete with endogenous target molecules for the oxidant [5, 6] . New approaches are focused on combating specific sources of oxidants using targeted redox medicine [4] .
Oxidants can react with redox sensitive targets in the cellular environment. These processes can occur through enzyme-mediated processes [7] . Much like other secondary messengers, specificity of a redox signal can be achieved through modulation of the microdomain [8] . For example, an accumulation of H 2 O 2 can be restricted to a microdomain via the local inhibition of oxidant scavenging enzymes [8, 9] . This allows the local oxidant concentration to rise to a moderate level to elicit a signaling response, yet prevent a toxic accumulation of H 2 O 2 [9] [10] [11] [12] . Fluorescent biosensors can measure oxidants including peroxynitrite [13] and H 2 O 2 [14] . These sensors can be targeted to specific regions, or microdomains, in the cell to detect localized changes in the redox state [15] . Alternatively, the modification of intracellular oxidant levels often relies on global exogenous administration of oxidants, application of toxins or mutations that cause continuous oxidant production.
Advances in photochemistry and optogenetics have led to the development of tools that offer simultaneous spatial and temporal control of oxidant production [16] . Fluorescent proteins are widely used to study redox biology. While most are employed for their fluorescent properties (e.g. oxidant biosensors), some fluorescent proteins produce oxidants in response to light. These proteins are genetically-encoded photosensitizers and can be targeted to distinct cellular compartments to study oxidant microdomains [16] . These tools have been used for a variety of applications, which require spatial and temporal control over oxidant production. Depending on their photochemistry, the photosensitizers can produce singlet oxygen ( 1 O 2 ) and O 2
Photosensitization
Oxygen-dependent photosensitization is a process that involves oxygen, light, and a photosensitizer. Photosensitizers are molecules, which, upon absorption of light, initiate the photochemical creation of oxidants. Photosensitizers may be synthesized endogenously or administered exogenously, as is done in medical therapeutic and diagnostic applications. When illuminated at an appropriate wavelength, the absorption of a photon of light results in the population of a shortlived excited singlet state (Fig. 1) [19, 20] . Once excited, the photosensitizer electron may return to the ground state by emission of fluorescence. Alternatively, the singlet state may evolve to a relatively longer-lived excited triplet state through the process of intersystem crossing [19, 20] . The triplet state may relax to the ground state through non-radiative mechanisms or via phosphorescence. Photosensitization is based on the efficient quenching of the triplet state by molecular oxygen, which is itself a triplet. It is this quenching of the photosensitizer triplet state by oxygen that generates the oxidant. Efficient photosensitizers, therefore, have high rates of intersystem crossing to the triplet state [21] . Oxygen-independent photosensitization can also occur via triplet-triplet energy transfer, whereby the photosensitizer triplet state is quenched by a target molecule [22] .
A triplet state photosensitizer can form either O 2 •-or 1 O 2 through a type I or type II mechanism, respectively ( Fig. 2 ). In the type I mechanism, the triplet state photosensitizer obtains an electron from its environment and becomes a radical species. In protein encased photosensitizers, the surrounding amino acids can act as electron donors. The reduced photosensitizer then reacts with oxygen to generate O 2
•-
. The type I mechanism may also include hydrogen abstraction from a target molecule, ultimately resulting in oxidation products [23] . However, this mechanism requires a close proximity between the triplet state photosensitizer and the target; an interaction which may be hindered by protein encasement of a photosensitizer [23] . In the type II mechanism, the triplet excited state transfers energy directly to oxygen to form 1 •- [24] [25] [26] . However, the relative importance of one or the other process is often influenced by intrinsic properties of the photosensitizer, oxygen concentration, surrounding environment and pH. Encasing the photosensitizer within a protein can confer some control over the local environment as well as provide selective cellular targeting of the photosensitizer [27] . Targeted light-induced production of oxidants is widely used in photodynamic therapy to treat cancer and local infections [20, [29] [30] [31] . Diseased cells are targeted with a photosensitizer and illuminated, resulting in selective destruction. The photosensitization mechanism to generate O 2
•-may compete with the mechanism to produce 1 O 2 . However, the contribution of a particular oxidant species to cell death is usually unclear. Current approaches to optimize the effectiveness of photodynamic therapy include improving selective targeting, intracellular localization of the photosensitizer to an oxidative-vulnerable compartment and designing photosensitizers that generate large yields of oxidants [27, 32] .
Measures of oxidants
The quantum yield of a particular oxidant is defined as the fraction of optical excitations that result in the formation of that oxidant. For example, rose bengal has a 1 O 2 quantum yield of 0.76 [33] . 1 O 2 is quantified using a number of methods that take advantage of its physical properties, such as phosphorescence at 1270 nm or its specific reaction products (reviewed in [34, 35] [5, 40] . In brief, photosensitization-mediated O 2
•-detection has typically relied on dihydroethidium (DHE) bleaching [41] or fluorescence of DHE-oxidation products [42] , which lack O 2
•--specific product separation [43, 44] . The photophysics in vitro may differ greatly from that in the cellular milieu. In biological systems researchers often use scavengers or enhancers to determine the oxidant responsible for an observed phenotype. 
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to oxidant detection, the limitations of oxidant scavenging must be considered [5] .
Application of photosensitizers
Photosensitizers offer temporal control over oxidant production. However, targeting photosensitizers for precise spatial control is an active area of research [48] [49] [50] [51] . Traditional photosensitizers such as rose bengal lack tissue selectivity. Furthermore, delivery and uptake of exogenous photosensitizers can be problematic, and stability and solubility may present challenges. Some intrinsic properties of photosensitizers allow them to accumulate in distinct cellular sites. For example, hydrophobicity and charge can lead to photosensitizer accumulation in lysosomes or mitochondria [52] . One approach for localized oxidant production to specific compartments is the use of genetically-encoded photosensitizers.
The applications of genetically-encoded photosensitizers are expanding and include mutagenesis, chromophore-assisted light inactivation (CALI), oxidant signaling, or cell ablation (reviewed [16] ) (Fig. 3 ). These approaches capitalize on the spatial and temporal control of oxidant production to mediate or manipulate biological effects. From the studies it is clear the location of the photosensitizer and the oxidant type and yield all contribute to the efficiency or effectiveness of the observed phenotype [16] . For example, cell ablation may require large scale oxidant production, while CALI-based approaches necessitate a restricted oxidant domain to prevent off-target damage to nearby proteins. In addition, factors such as the type of chromophore, oxidant production capabilities, stability and maturation can impact the effectiveness of a genetically-encoded photosensitizer for one approach over another. However, which specific oxidant that mediates the mechanism of action is often limited. Here we will review the chromophores and oxidant production of fluorescent proteins.
Genetically-encoded photosensitizers
The ideal fluorescent protein chromophore for typical applications (i.e. as a fluorescent probe) will efficiently absorb the excitation light and have a high fluorescence quantum yield with little intersystem crossing (Fig. 1) . However, some chromophores of fluorescent proteins can act as efficient photosensitizers [16] . These chromophores may, following illumination, have a high rate of intersystem crossing to form the excited triplet state and subsequently generate oxidants. In general, fluorescence competes with intersystem crossing to the excited triplet state, thereby rendering fluorescence quantum yield and oxidant yield inversely correlated [53] . Oxidant production by commonly used fluorescent proteins is often overlooked. The following sections will examine light-dependent and -independent oxidant production of GFP, TagRFP, mCherry, KillerRed, SuperNova, KillerOrange, and miniSOG.
Green fluorescent protein (GFP)
Green fluorescent protein (GFP) is a widely used essential tool for many imaging approaches [54] . GFP expression in cells can be toxic [55, 56] , which may be the result of both light-dependent and independent mechanisms of oxidant production. Independent of light, the maturation of GFP chromophore can non-catalytically produce H 2 O 2 [57] . However, recent studies using Electron Spin Resonance (ESR) spectroscopy and fluorescence assays demonstrated that the maturation process can catalytically produce O 2
•-and H 2 O 2 in the presence of NAD (P)H, an electron source [58] . The catalytic production was linked to an immature chromophore, since both mature GFP and a GFP chromophore mimetic did not produce oxidants or consume NADH [58] . HeLa cells stably expressing GFP had increased rates of oxidant production, which led to changes in gene expression in oxidant responsive pathways [58] . Overall, mere expression of GFP in cells may impact the redox status [58, 59] . GFP also generates oxidants in response to illumination. GFP fusion proteins have been important tools for use in CALI and electron microscopy because of the oxidant production [60] [61] [62] [63] . CALI and electron microscopy use spatially restricted oxidant production to selectively oxidize target proteins or form electron-dense precipitates, respectively [60, 61, 63, 64] [65, 66] . Although GFP oxidant production is of lower magnitude compared with other phototoxic proteins (Table 1) , GFP controls must be interpreted carefully in studies looking at oxidant production or oxidative stress outputs.
TagRFP
TagRFP is a red fluorescent protein (RFP) derived from TurboRFP with a chromophore consisting of a Met63-Tyr64-Gly65 (MYG) amino acid motif [68, 69] . Much like GFP, the maturation of the TagRFP chromophore generates oxidants [69] [68] , however, illumination of mCherry resulted in bleaching of DHE and minimal ADPA photobleaching, suggesting a primary role for O 2
•- [41] . Aside from the chromophore, the structural residues that interact or stabilize the chromophore may play a role in the phototoxic mechanism, since mCherry and TagRFP are derived from different RFPs [73] . Genetically-encoded photosensitizers offer spatial and temporal control over oxidant production. The type of oxidative reactions elicited by a genetically encoded photosensitizer depends upon the type(s) of oxidants produced. They can produce freely diffusible oxidants to induce oxidant signaling or utilize localized production of highly reactive oxidants for increased correlative light Electron Microscopy (EM) resolution. In addition, the site of generation (e.g. cytosolic or mitochondrial) and the amount of oxidants produced will impact the application. Localized oxidant production can be used for target protein inactivation while bolus widespread production can result in cellular destruction. Abbreviations: PDT, photodynamic therapy; CALI, chromophore assisted lightinactivation.
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KillerRed
Traditional fluorescent proteins such as GFP and TagRFP have weak photosensitization properties and were intended to be stable and have a high fluorescence quantum yield. KillerRed was the first fluorescent protein designed to be phototoxic [74] . KillerRed is a red fluorescent protein derived from anm2CP, a non-fluorescent chromoprotein discovered in the bioluminescent hydrozoan jellyfish Anthomedusae sp [74, 75] . Specifically, KillerRed was engineered by random and sitedirected mutagenesis of anmCP2, and the resulting 20 amino acid substitutions led to its fluorescent characteristics [74] . KillerRed's structure was determined by Carpentier et al. [76] and Pletnev et al. [77] . Their crystallographic studies revealed a GFP-like, 11-stranded β-barrel structure and its propensity to dimerize. Importantly, the structural rearrangement resulting from the engineered amino acid substitutions creates a pore in the β-barrel resulting in a water channel leading through the center of the barrel to the chromophore. The chromophore is located within a region of α-helices in the center of the β-barrel and is stabilized by the surrounding mutated residues (particularly Glu68 and Ser119). The KillerRed chromophore consists of three key residues, Gln65-Tyr66-Gly67 (QYG). Upon chromophore maturation, the hydroxybenzylidene and imadazolinone two-ring structure is formed, which absorbs photons in the yellow/amber wavelength spectrum. As opposed to the non-fluorescent chromophore in anmCP2, which is in a trans configuration relative to the preceding Ile64, KillerRed's chromophore is in a cis configuration due to an Nacylimine double bond, which is typical in fluorescent proteins [76, 77] .
The mutations introduced by Bulina et al. gave KillerRed its properties as a photosensitizer. This was initially demonstrated by its phototoxic effects on E. coli colony formation and in eukaryotic cells [74] . More recently, a growing body of literature has reported the use of KillerRed for CALI and neural photoablation, which involves fusing KillerRed to a protein of interest or expressing with a localizing sequence to target a specific organelle or compartment (e.g. mitochondria, endoplasmic reticulum) [78] [79] [80] [81] . Additionally, antibody-KillerRed fusion constructs have been used for photodynamic therapy [82, 83] . While KillerRed has been used widely for CALI and photoablation experiments, less attention has been paid to its use for induction of redox signaling via oxidant sensitive targets [16] .
Whether KillerRed photosensitization in cells occurs via type I or II photochemistry has been debated. In the original report by Bulina et •-is required for photosensitization in vivo.
The precise identity of the oxidant(s) generated by KillerRed and the mechanism of photosensitization has also been discussed in the photochemistry literature. Protein structural analysis suggests that upon photosensitization, electron transfer may occur from the excited triplet state chromophore's π-conjugated system to oxygen in the water channel, forming O 2
•-in a type I reaction [76, 77] . The water channel is likely a key factor in the chromophore's photosensitization mechanism. For instance, this type of water channel is involved in the electron transfer function of other proteins [85] . Although water channels are found in other non-phototoxic proteins, only KillerRed has the corresponding pore on the outside of the β-barrel to provide solvent access to the chromophore proximally, and allow oxidant release distally. This type I mechanism of phototoxicity was questioned by Roy et al. [86] , who used molecular dynamics simulations to determine that the majority of the O 2 •-anions were attracted to a positively charged Arg94 pocket near the chromophore and were therefore unlikely to directly escape the β-barrel. While these authors speculate that type II 1 O 2 formation could occur instead, they conclude that type I O 2
•-formation and release may occur via long-range electron transfer through a proton wire of hydrogen bonds within the water channel [86] . Subsequent investigations support this hypothesis with experimental data. Vegh et al. [87] showed that a phosphorescence signal detected at 1270 nm after KR excitation in the presence or absence of D 2 O belonged to the triplet state of the photosensitizer and not 1 O 2 . Additionally, it was also clearly shown using TEMPO-9-ac and DMPO probes that KillerRed generates and releases radical species consistent with the characteristics of O 2
•- [87] . Collectively, it appears that KillerRed primarily generates radicals via type-I photochemistry as a result of 1) a water filled channel connecting an outer pore with the chromophore, 2) residues which stabilize the cis form of the chromophore, and 3) residues next to the chromophore that become key reactive residues. Interestingly, TagRFP, which primarily makes 1 O 2 [71] , lacks a clear channel linking the solvent to the chromophore [69] .
Despite its well-known efficacy as a photosensitizer, there are some potential limitations to using KillerRed in vivo. Chief among these is the necessity to dimerize to form a mature oxidant-producing photosensitizer. The dimerization can induce expression artifacts, and the [41] n/a + [41] Phototoxicity via type I mechanism; monomeric. mKillerOrange QWG [94] 512/555 0.42 [93] n/a n/a Uncharacterized photosensitization mechanism at present. miniSOG Flavin mononucleotide [84] 448/528 0.37 [84] 0.030 [38, 42] + [26, 42] Requires FMN incorporation during maturation; considerably lower Φ 1 O 2 than initially reported [84] .
n/a, data not available; '−' low or not detected; '+' detectable levels of generation; '*' measured using 4-hydroxybenzylidene-1,2-dimethylimidazoline.
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resulting bulky construct can interfere with the endogenous function of the protein to which it is fused [41] . A pseudo-monomeric variant known as tandem KillerRed can be used to address these issues in vivo.
In addition, KillerRed photobleaches more readily than other fluorescent proteins [74] . This may be due to the redox cycling that can degrade the chromophore, particularly at Gln65 and Tyr66 residues. Redox cycling is exacerbated in KillerRed by the greater access of molecular oxygen via the water channel, which is thought to be necessary for photobleaching. This occurs despite the fact that KillerRed is somewhat protected from self-sensitization by 16 sulfur-containing moieties throughout the β-barrel that can scavenge oxidants [76] . An initial step of the photobleaching process may be the photoreduction of the chromophore [88] , which leads to photoinduced isomerization of the chromophore and loss of fluorescence [89] . Interestingly, marked improvements in resistance to photobleaching have recently been made in RFPs by introducing a cysteine residue proximal to the chromophore, which upon photosensitization is sulfoxidized, protecting it against further radical-mediated damage and photobleaching [90] . Whether this could be incorporated into new variants of KillerRed remains to be determined. Finally, care needs to be taken in the design and interpretation of in vivo experiments due to the temporal requirements of chromophore maturation. In an attempt to address some of these limitations, a monomeric version of KillerRed, SuperNova [41] , was recently developed.
SuperNova
As noted above, despite KillerRed's advantages as a genetically encoded photosensitizer, its practicality is severely limited by the necessity of dimerization to form a functional chromophore. KillerRed dimerization may interfere with proper localization and compromise the function of fusion proteins [41] . SuperNova was developed from KillerRed to be a fluorescent protein with identical optical and phototoxic properties but to be functional in its monomeric form [41] .
Initial efforts to develop a monomeric version of KillerRed focused on altering the residues in a hydrophobic region predicted to be the interface between KillerRed monomers. Using site directed mutagenesis, two residues located in the dimerization interface (Leu160 and Phe162) were mutated. While these substitutions resulted in a monomeric protein, the absorbance and fluorescence intensity were lost. Additional mutations restored fluorescence and phototoxicity [41] . SuperNova retains the water-filled channel linking the chromophore to the solvent and other structural features of KillerRed. However, SuperNova is less photostable in Hela cells and has a faster fluorescence recovery after photobleaching than KillerRed in vitro. The chromophore structure is highly similar to KillerRed, which is formed by a Gln65-Tyr66-Gly67 (QYG) motif at the center of the helix. In KillerRed, Asn145 stabilized the fluorescent Cis conformation of the chromophore. However, in SuperNova Asn145 was mutated to Ser. In order to confirm that the oxidant generation of SuperNova was not compromised by the mutation, 1 to mitochondria, SuperNova phototoxicity induced apoptosis in~77% of cells after 90 s of intense illumination. In addition to cell ablation, SuperNova is effective in CALI-based approaches [91, 92] . Notably, the distance between SuperNova and the target site directly impacted the effectiveness of CALI. However, the identity of the inactivating oxidant in vivo is unclear [92] .
KillerOrange
In order to expand the palette of phototoxic proteins, KillerOrange was generated from KillerRed [93] . After making a Tyr66Trp mutation in the chromophore of KillerRed and several rounds of random mutagenesis to increase fluorescence intensity (Gly3Cys, Tyr66Trp, Asp113Ser, Asn145Ser, Phe177Leu, Tyr221His, Glu236Gln), a blueshifted, orange fluorescent variant of KillerRed was characterized [93] . The new protein, KillerOrange, was phototoxic to both bacterial and mammalian cells. The photoactivation of KillerOrange does not activate KillerRed and allows the two proteins to be used simultaneously in a single system [93] . Like KillerRed, KillerOrange is dimeric. A monomeric version of KillerOrange was created by a single mutation (Tyr66Trp) to the SuperNova chromophore, resulting in the Gln65-Trp66-Gly67 (QWG) chromophore [94] . A crystal structure of KillerOrange revealed a water-accessible chromophore like in KillerRed, but with a rare trans-cis conformation of the Trp66, likely giving rise to the orange fluorescence [94] . The mechanism of oxidant production is thought to be the same type I (radical) reaction of KillerRed, but further characterization of KillerOrange is necessary.
miniSOG
Mini singlet oxygen generator (miniSOG) is a green fluorescent protein derived from the LOV domain of Arabidopsis thaliana phototropin 2 [84] . Unlike the genetically encoded protein chromophores of KillerRed or GFP, the chromophore of miniSOG is the endogenous cofactor, flavin mononucleotide (FMN). Upon blue light illumination, FMN can act as photosensitizer and generate both O 2
•-and 1 O 2 in solution [26, 95, 96] . Originally, emphasis was placed on the large 1 O 2 quantum yield of miniSOG, which mimicked that of free FMN [84] . However, more recent reports demonstrated that the 1 O 2 yield is much lower and is dependent on radiant exposure [38, 42] . Additionally, miniSOG produced comparatively less O 2
•-than FMN measured using DHE fluorescence [42] and the O 2
•--specific product, 2-hydroxyethidium [26] . Overall, the protein encasement of FMN can alter the local environment and change the oxidant production capabilities. miniSOG is used for a variety of approaches as an optogenetic tool, including CALI [97, 98] , cell ablation [99] [100] [101] [102] , identifying localized structures via electron microscopy [84, [103] [104] [105] and mutagenesis [106] . While miniSOG produces both 1 O 2 and O 2
•-, the oxidant implicated remains unclear in many of these applications. One study alludes to a role for 1 O 2 , since the loss of the O 2
•-scavenger, SOD, had no impact on phototoxicity [102] . miniSOG is a comparatively small protein-encoded photosensitizer and will have less impact on fusion protein functionality as compared to tandem KillerRed (~15 kDa vs 54 kDa). However, miniSOG is activated by blue light, which can activate other endogenous photosensitizers like free FMN. Efforts to limit miniSOG-independent phototoxicity centered on increasing miniSOG's oxidant production, thus enabling decreased light exposure. The miniSOG structure was mutated to generate variants with a higher oxidant production and include singlet-oxygen-producing protein (SOPP) [107] , SOPP2, SOPP3 [108] and miniSOG2 [109] . SOPP was generated using site directed mutagenesis of miniSOG (Gln103Leu). The single mutation resulted in a larger 1 O 2 quantum yield [107] and a protein that was more phototoxic than miniSOG [102] . Likewise, additional mutations to SOPP resulted in SOPP2, from which SOPP3 was derived [108] . Mutations were introduced to limit potential electron donating residues to reduce O 2
•-production. The resulting miniSOG variants had an increased 1 O 2 yield [108] . However, the O 2 •-production rate remains to be quantified, and the selectivity of 1 O 2 production by SOPP3 requires further examination. miniSOG2 is another variant derived from miniSOG by the introduction of seven mutations. Four of the mutations surround the FMN chromophore (Arg57His, Gln44Arg, Gly40Pro and Leu84Phe) and may impact the production of oxidants [109] . The illumination of miniSOG2 resulted in azide-sensitive caspase activation in mammalian cells. The radical scavenger mannitol showed a small inhibition of caspase activation and supports a primary role for 1 O 2 in mediating miniSOG2 phototoxicity [109] . Overall, the miniSOG variants will allow for a less intense light dose to achieve the same amount of oxidant production, thereby limiting off-target effects of light. 
Conclusion and future directions
Genetically-encoded photosensitizers are rapidly expanding the redox biologist's toolbox. With the ability to precisely target and control oxidant production, researchers can generate oxidants in vivo without the use of irreversible toxins or global application of oxidants [16] . However, light is not necessarily benign, and full characterization of oxidants produced by photosensitizers is often overlooked. Cells contain endogenous photosensitizers (e.g. FMN) that are activated by blue light and can cause off-target effects. Moreover, light propagation through tissues is dependent on the wavelength, such that longer wavelengths can permeate tissue deeper than shorter wavelengths [20] . While in model organisms such as C. elegans this does not pose a limitation, the translation to mammalian systems may be problematic and require invasive lighting approaches. New advances in lighting techniques will bring light to difficult to access regions. One approach uses bioluminescence resonance energy transfer to directly couple a photosensitizer (e.g. miniSOG) to a light producing system (e.g. nanoLuc) [112] . Additionally, photosensitizers that are effective using near infrared light are rapidly advancing and allowing photodynamic therapy to reach deep within a tissue [113] .
The number of genetically-encoded photosensitizers is growing, and each variant improves the selectivity and oxidant yield. The efficiency with which oxidants are produced in response to light depends on a photosensitizer's capability to enter the excited triplet state (Fig. 1 ) [21] , and not all fluorescent proteins are efficient photosensitizers. A long-lived triplet state increases the likelihood of interacting with oxygen to form oxidants [21] . The contribution of 1 O 2 or O 2
•-(and downstream oxidants) to observed phenotypes is often unclear, and interpretations should consider both species. Overall, advances in lighting and improvements in oxidant yield and selectivity will continue to make genetically-encoded photosensitizers indispensable to the advancement of redox biology.
